Eflora CREAM (VANIQA)13.9%w/v

Name: Eflora CREAM (VANIQA)13.9%w/v
SKU: a18f37c9a66e
Availability: InStock

USD $38.85

Each Eflora cream contains 13.9% Eflornithine 15 grams and is used in the treatment of hirsutism (unwanted facial hair growth), in women.

ATC Classification: D11AX16, P01CX03
Active Ingrediant: Eflornithine Hydrochloride
Generic Name: Eflora CREAM
Manufacturer: Ranbaxy Limited
Strength: 13.9%w/v
Dosage Type: Cream
Packaging Type: Box
Contains: 15 gm

Important update for customers in the USA:

The World has stopped all packages mailing to the USA due to De Minimus Exemption.

This situation is real and affects the world, not just India. See your local news or this Fox Business report .
We got through COVID; we will get through this as well.
By law we must temporarily remove Card and eCheck for USA shipments because we cannot mail today.
Suggestion: order now to hold your place — shipping will be first-come, first-served once mailing resumes (mail is already queued).
Waiting to place your order is fine; we expect resolution soon, but mail is piling up worldwide, not only with our firm.
We ship normally to the UK, AUS, Japan, and most others. The hold is on the USA side only.

Thanks for your patience.

Ranbaxy

Pronunciation

(ee FLOR ni theen)

Medication Safety Issues

Sound-alike/look-alike issues:

Vaniqa may be confused with Viagra

Storage/Stability

Cream: Store at controlled room temperature 25?C (77?F); excursions permitted to 15?C to 30?C (59 ?F to 86?F); do not freeze.

Injection: Use within 24 hours of preparation.

Adverse Reactions

Injection (Priotto 2009):

Cardiovascular: Cardiac arrhythmia, chest pain, edema, hypertension, hypotension, shock

Central nervous system: Amnesia, anxiety, ataxia, coma, confusion, depression, dizziness, hallucination, headache, insomnia, lethargy, peripheral neuropathy, seizure

Dermatologic: Pruritus, skin rash

Endocrine & metabolic: Dehydration

Gastrointestinal: Abdominal pain, anorexia, constipation, diarrhea, dysgeusia, dysphagia, hiccups, nausea, vomiting, xerostomia

Genitourinary: Change in creatinine, urinary frequency, urinary incontinence, urinary urgency

Hematologic & oncologic: Anemia, leukopenia, neutropenia, thrombocytopenia

Hepatic: Abnormal bilirubin levels, increased serum transaminases

Infection: Infection

Local: Extravasation, injection site reaction

Neuromuscular & skeletal: Arthralgia, myalgia, tremor, weakness

Otic: Inner ear disturbance

Respiratory: Cough, dyspnea, epistaxis, respiratory distress

Miscellaneous: Fever

Additional information

Active Ingrediant	VANIQA
Generic Name	Eflora
Alternate Names	Clearoswab, Eflornithine, Florexa, Flornith, Malsa, Vanihair, Vaniqa
Strength	13.9%w/v
Dosage Type	Cream
Packaging Type	Box